RNO — Rhinomed Income Statement
0.000.00%
Last trade - 00:00- AU$11.43m
- AU$17.21m
- AU$7.47m
- 22
- 43
- 34
- 26
Annual income statement for Rhinomed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.3 | 3.58 | 3.89 | 9.1 | 7.47 |
| Cost of Revenue | |||||
| Gross Profit | 2.21 | 2.13 | 2.75 | 6.21 | 5.59 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.3 | 11.5 | 13 | 14.3 | 18.1 |
| Operating Profit | -6 | -7.94 | -9.15 | -5.24 | -10.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.93 | -7.27 | -8.64 | -5.28 | -10.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.94 | -7.27 | -8.64 | -5.28 | -10.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.94 | -7.27 | -8.64 | -5.28 | -10.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.94 | -7.27 | -8.64 | -5.28 | -10.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.044 | -0.045 | -0.034 | -0.02 | -0.033 |